Suppr超能文献

慢性血栓栓塞性肺动脉高压的外科及内科治疗作用:一项系统评价

Role of Surgical and Medical Management of Chronic Thromboembolic Pulmonary Hypertension: A Systematic Review.

作者信息

Crowley Alexandra V, Banfield Megan, Gupta Aditi, Raj Rhea, Gorantla Vasavi R

机构信息

Medicine, St. George's University School of Medicine, True Blue, St. George's, GRD.

Biomedical Sciences, West Virginia School of Osteopathic Medicine, Lewisburg, USA.

出版信息

Cureus. 2024 Jan 31;16(1):e53336. doi: 10.7759/cureus.53336. eCollection 2024 Jan.

Abstract

Chronic thromboembolic pulmonary hypertension (CTEPH) is underdiagnosed and has recently surfaced as one of the leading triggers of severe pulmonary hypertension. This disease process is described by structural changes of pulmonary arteries such as fibrous stenosis, complete obliteration, or the presence of a resistant intraluminal thrombus, resulting in increased pulmonary resistance and eventually progressing to right-sided heart failure. Hence, this study aims to describe the current treatments for CTEPH and their efficacy in hemodynamic improvement and prevention of recurring thromboembolic episodes in patients. This systematic review promptly follows the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines. On February 13, 2022, our team searched through the following databases: PubMed, ProQuest, and ScienceDirect. The following keywords were used across all databases: CTEPH AND Pulmonary Endarterectomy (PEA), CTEPH AND Balloon Pulmonary Angioplasty (BPA), and CTEPH AND Medical Therapy OR Anticoagulation therapy. Twenty-nine thousand eighty-nine articles on current management techniques (PEA, Balloon angioplasty, anticoagulants) were selected, analyzed, and reviewed with each other. We found 19 articles concerning PEA, 15 concerning BPA, and six regarding anticoagulants. Most papers showed high success rates and promising evidence of PEA and anticoagulants as a post-operative regimen. BPA was the least preferred but is still reputable in patients unfit for invasive techniques. CTEPH is a condition presenting with either fibrous stenosis, complete obliteration of the artery, or a clogged thrombus. Recent studies have shown three techniques that physicians have used to treat CTEPH: balloon-pulmonary angioplasty, PEA, and medical management with anticoagulants. PEA followed by anticoagulants is preferred to balloon pulmonary angioplasties. CTEPH is an ongoing topic in research; as it continues to be researched, we hope to see more management techniques available.

摘要

慢性血栓栓塞性肺动脉高压(CTEPH)的诊断不足,最近已成为严重肺动脉高压的主要诱因之一。这种疾病过程表现为肺动脉的结构变化,如纤维性狭窄、完全闭塞或腔内存在顽固血栓,导致肺阻力增加,最终发展为右心衰竭。因此,本研究旨在描述CTEPH的当前治疗方法及其在改善血流动力学和预防患者复发性血栓栓塞事件方面的疗效。本系统评价严格遵循系统评价和Meta分析的首选报告项目(PRISMA)指南。2022年2月13日,我们的团队检索了以下数据库:PubMed、ProQuest和ScienceDirect。所有数据库都使用了以下关键词:CTEPH与肺动脉内膜剥脱术(PEA)、CTEPH与球囊肺血管成形术(BPA)、CTEPH与药物治疗或抗凝治疗。我们筛选、分析并相互审阅了29089篇关于当前管理技术(PEA、球囊血管成形术、抗凝剂)的文章。我们发现19篇关于PEA的文章、15篇关于BPA的文章和6篇关于抗凝剂的文章。大多数论文显示PEA和抗凝剂作为术后治疗方案的成功率很高且证据充分。BPA是最不常用的,但在不适合采用侵入性技术的患者中仍享有声誉。CTEPH表现为纤维性狭窄、动脉完全闭塞或血栓堵塞。最近的研究表明,医生用于治疗CTEPH的三种技术是:球囊肺血管成形术、PEA和抗凝药物治疗。PEA后使用抗凝剂优于球囊肺血管成形术。CTEPH是一个持续研究的课题;随着研究的不断深入,我们希望能看到更多的管理技术。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/900f/10907114/78e95f3fa7a6/cureus-0016-00000053336-i01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验